Recruiting OBSERVATIONAL NCT05830279

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

Evaluating the Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer Patients: A Prospective Longitudinal Trial

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions Cancer Pain Depression, Reactive Nausea With Vomiting Chemotherapy-Induced

Interventions Drug-Drug interaction analysis Pharmacogenetic testing

Updated 7 times since 2023 Last updated: Jul 4, 2025 Started: May 1, 2023 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cancer Pain and Depression, Reactive, this trial is actively recruiting participants. The trial is conducted by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's and has accumulated 7 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Recruiting
Apr 2025 — Aug 2025 [monthly]

Recruiting
Jan 2025 — Apr 2025 [monthly]

Recruiting
Sep 2024 — Jan 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Nov 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2023 — Nov 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Data source: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada